[Pharmacokinetics of acebutolol in renal failure]. 1976

P Aubert, and A Roux, and B Flouvat, and M Lucsko, and M Chaignon, and J Guédon

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D007700 Kinetics The rate dynamics in chemical or physical systems.
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000070 Acebutolol A cardioselective beta-1 adrenergic antagonist with little effect on the bronchial receptors. The drug has stabilizing and quinidine-like effects on cardiac rhythm, as well as weak inherent sympathomimetic action. Acebutolol Hydrochloride,Acetobutolol,Apo-Acebutolol,M & B 17803A,M&B-17803 A,Monitan,Neptal,Novo-Acebutolol,Prent,Rhotral,Sectral,Apo Acebutolol,ApoAcebutolol,M&B 17803 A,M&B17803 A,Novo Acebutolol,NovoAcebutolol

Related Publications

P Aubert, and A Roux, and B Flouvat, and M Lucsko, and M Chaignon, and J Guédon
September 1983, British journal of clinical pharmacology,
P Aubert, and A Roux, and B Flouvat, and M Lucsko, and M Chaignon, and J Guédon
December 1975, La Nouvelle presse medicale,
P Aubert, and A Roux, and B Flouvat, and M Lucsko, and M Chaignon, and J Guédon
April 1991, Journal of pharmaceutical sciences,
P Aubert, and A Roux, and B Flouvat, and M Lucsko, and M Chaignon, and J Guédon
November 1983, Anaesthesia and intensive care,
P Aubert, and A Roux, and B Flouvat, and M Lucsko, and M Chaignon, and J Guédon
August 2002, Archives of pharmacal research,
P Aubert, and A Roux, and B Flouvat, and M Lucsko, and M Chaignon, and J Guédon
April 1976, Clinical pharmacology and therapeutics,
P Aubert, and A Roux, and B Flouvat, and M Lucsko, and M Chaignon, and J Guédon
February 1987, Antimicrobial agents and chemotherapy,
P Aubert, and A Roux, and B Flouvat, and M Lucsko, and M Chaignon, and J Guédon
June 1987, Chemioterapia : international journal of the Mediterranean Society of Chemotherapy,
P Aubert, and A Roux, and B Flouvat, and M Lucsko, and M Chaignon, and J Guédon
March 1987, Anesthesiology,
P Aubert, and A Roux, and B Flouvat, and M Lucsko, and M Chaignon, and J Guédon
February 1976, British journal of clinical pharmacology,
Copied contents to your clipboard!